These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8941949)

  • 1. Antifibrinolytic activity of epsilon-aminocaproyl derivatives of amino acids.
    Midura-Nowaczek K; Bruzgo I; Dubis E; Roszkowska-Jakimiec W; Worowski K
    Pharmazie; 1996 Oct; 51(10):775-7. PubMed ID: 8941949
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of epsilon-aminocaproylamino acids on fibrin formation.
    Bruzgo I; Midura-Nowaczek K; Bruzgo M; Kaczyńska J; Roszkowska-Jakimiec W
    Acta Pol Pharm; 2006; 63(2):149-52. PubMed ID: 17514879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of epsilon-aminocaproyl-S-benzyl-L-cysteine on the activity of plasminogen activators.
    Bruzgo I; Midura-Nowaczek K; Kaczyńska J; Krajewska D
    Acta Pol Pharm; 2009; 66(1):37-40. PubMed ID: 19226966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and activity of N epsilon-aminocaproyl-L-norleucine derivatives.
    Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Worowski K
    Acta Pol Pharm; 1996; 53(3):221-3. PubMed ID: 8960292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical use of synthetic antifibrinolytic agents during liver transplantation.
    Kang Y
    Semin Thromb Hemost; 1993; 19(3):258-61. PubMed ID: 8362255
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of epsilon-aminocaproiloaminoacids on the amidolytic activity of tissue plasminogen activator, urokinase and kallikrein.
    Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Markowska A
    Acta Pol Pharm; 2004; 61(1):75-6. PubMed ID: 15259861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and activity of dipeptides containing epsilon-aminocaproic acid.
    Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Worowski K
    Acta Pol Pharm; 1994; 51(6):499-504. PubMed ID: 7762400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of fibrinolytic activity after epsilon-aminocaproic acid administration in rats (Rattus norvegicus).
    Gogjian MA; Barry KJ; Stein BM
    Lab Anim Sci; 1981 Dec; 31(6):710-1. PubMed ID: 7343767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of some epsilon-aminocaproic acid derivatives on platelet responses.
    Bruzgo I; Tomasiak M; Stelmach H; Midura-Nowaczek K
    Acta Biochim Pol; 2004; 51(1):73-80. PubMed ID: 15094827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antifibrinolytic and antimycotic properties of 2-thiontetrahydro-1,3,5-thiadiazine].
    Kleking GR; Viurbakh G
    Farmakol Toksikol; 1976; 39(4):432-6. PubMed ID: 1088410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effective concentration of epsilon-aminocaproic Acid for inhibition of fibrinolysis in neonatal plasma in vitro.
    Yurka HG; Wissler RN; Zanghi CN; Liu X; Tu X; Eaton MP;
    Anesth Analg; 2010 Jul; 111(1):180-4. PubMed ID: 20519417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic antifibrinolytic action of the potato protease inhibitor and epsilon-aminocaproic acid.
    Worowski K
    Acta Biol Acad Sci Hung; 1976; 27(2-3):125-8. PubMed ID: 140568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of dipeptide derivatives of S-substituted cysteines on the time of fibrinolysis.
    Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Worowski K
    Rocz Akad Med Bialymst; 1996; 41(2):412-6. PubMed ID: 9020554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The action of fibrinolysis inhibitors of the omega-aminocarboxylic acid type on the proliferation of in vitro cultured endothelial cells].
    Pilgrim H
    Pharmazie; 1986 Jul; 41(7):519-20. PubMed ID: 3490674
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of epsilon-aminocaproylaminoacids on fibrinolytic and caseinolytic activity of euglobulin fraction.
    Midura-Nowaczek K; Bruzgo I; Popławski J; Roszkowska-Jakimiec W; Worowski K
    Acta Pol Pharm; 1998; 55(2):159-61. PubMed ID: 9673155
    [No Abstract]   [Full Text] [Related]  

  • 16. [Activity of antifibrinolytics when administered using a direct current].
    Krylov IuF; Loginova VA; Efanov OI
    Farmakol Toksikol; 1978; 41(1):80-2. PubMed ID: 304816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of epsilon-aminocaproylaminoacids on the activity of proteolytic enzymes.
    Bruzgo I; Midura-Nowaczek K; Roszkowska-Jakimiec W; Jasielczuk J
    Acta Pol Pharm; 2001; 58(2):137-40. PubMed ID: 11501792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the antifibrinolytic activity of the esters of 4-aminomethylbenzoic acid (PAMBA)].
    Markwardt F; Neuland P; Klöcking HP
    Pharmazie; 1966 Jun; 21(6):345-8. PubMed ID: 6000982
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of epsilon-amino-caproic acid, acetyl-epsilon-amino-caproic acid and trasylol on allergic reactions induced by dinitrochlorobenzen in guinea pigs.
    Onisk Z; Tchórzewski H
    Pol Med J; 1968; 7(1):190-5. PubMed ID: 5300915
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative studies on the fibrinolysis inhibitors AMCHA, epsilon-ACA and PAMBA].
    Fischer M
    Wien Z Inn Med; 1966 Apr; 47(4):143-53. PubMed ID: 6005160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.